Leap Therapeutics, Inc.
LPTX
Revenue
375.00k
0.000.00%
3 Months ChangeAssets
81.43M
▲23.46M▲40.48%
3 Months ChangeLiabilities
15.64M
▲5.05M▲47.65%
3 Months ChangeFree Cash Flow
-6.41M
▼-6.41M-∞%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-30
Form 8-K
ID: 0001104659-24-103942
2024-08-12
Form 8-K
ID: 0001104659-24-088051
2024-08-12
Form 10-Q
ID: 0001410578-24-001284
2024-07-08
Form 8-K
ID: 0001104659-24-078325
2024-05-13
Form 8-K
ID: 0001104659-24-060199
2024-05-13
Form 10-Q
ID: 0001410578-24-000748
2024-04-11
Form 8-K
ID: 0001104659-24-046108
2024-03-18
Form 8-K
ID: 0001104659-24-035239
2024-01-23
Form 8-K
ID: 0001104659-24-005944
2024-01-16
Form 8-K
ID: 0001104659-24-004162